Mode
Text Size
Log in / Sign up

Oncology

601 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Gedatolisib plus fulvestrant with or without palbociclib improved progression-free survival versus fulvestrant monotherapy in advanced breast cancer.
Oncology RCT
Gedatolisib plus fulvestrant with or without palbociclib improved progression-free survival versus fulvestrant monotherapy in advanced breast cancer. New Drug Combo Slashes Breast Cancer Progression Risk by 75%
This phase III randomized trial evaluated gedatolisib plus fulvestrant with or without palbociclib in patients with hormone receptor-positiv…
For patients with tough-to-treat advanced breast cancer, a new three-drug combination nearly quadrupled the time before the cancer started g…
Retrospective cohort of 443 glioma patients analyzed under successive WHO classifications from 2007 to 2021.
Oncology Cohort
Retrospective cohort of 443 glioma patients analyzed under successive WHO classifications from 2007 to 2021. Study reviews glioma diagnosis changes with updated WHO classification criteria
This retrospective analysis of a cohort from a high-volume Latin American center evaluated 443 patients undergoing elective tumor surgery be…
New WHO rules mean nearly a quarter of brain tumors in Latin America are now labeled 'not otherwise specified' due to limited molecular test…
Neoadjuvant atezolizumab shows spatial biomarker changes in operable urothelial carcinoma patients.
Oncology Phase II
Neoadjuvant atezolizumab shows spatial biomarker changes in operable urothelial carcinoma patients. How a Bladder Cancer Drug Remodels the Tumor Neighborhood
This single-arm, phase II trial evaluated neoadjuvant atezolizumab in patients with operable urothelial carcinoma. Results indicated that ce…
A bladder cancer drug physically breaks down the walls blocking immune cells in tumors, helping doctors predict which patients will respond …
Bayesian network meta-analysis of exercise interventions for depression and anxiety in cancer survivors
Oncology Meta-analysis
Bayesian network meta-analysis of exercise interventions for depression and anxiety in cancer survivors Mind-Body Exercises Top New Depression and Anxiety Relief List
This Bayesian network meta-analysis evaluated different exercise interventions versus non-exercise controls for depression and anxiety in 7,…
Slow, gentle movement like Tai Chi and Pilates now ranks highest for easing depression and anxiety in cancer survivors, offering a practical…
Narrative review examines multimodal AI for glioma using neuroimaging and hematologic biomarkers.
Oncology Sys. Review
Narrative review examines multimodal AI for glioma using neuroimaging and hematologic biomarkers. AI May Help Doctors Spot Brain Tumors Without Surgery
This narrative review explores the potential of multimodal artificial intelligence (AI) integrating neuroimaging and hematologic biomarkers …
This approach could make brain tumor diagnosis and monitoring less invasive and more precise.
Meta-analysis shows local consolidative therapy plus systemic therapy improves survival in driver-negative oligometastatic NSCLC.
Oncology Meta-analysis
Meta-analysis shows local consolidative therapy plus systemic therapy improves survival in driver-negative oligometastatic NSCLC. For a specific lung cancer group, adding local treatment to standard drugs significantly improved survival time.
This systematic review and meta-analysis evaluated local consolidative therapy combined with systemic therapy versus systemic therapy alone …
Adding local treatment to standard drugs significantly improved survival time for a specific lung cancer group with spread to only a few pla…
Adjunctive Chinese herbal medicine associated with symptom improvement in 83 breast cancer patients receiving Western medicine.
Oncology Cohort
Adjunctive Chinese herbal medicine associated with symptom improvement in 83 breast cancer patients receiving Western medicine. Herbs May Ease Breast Cancer Symptoms
This prospective observational study evaluated 83 patients with breast cancer receiving Western medicine alongside adjunctive scientific Chi…
Women using Chinese herbs alongside breast cancer treatment reported less fatigue, fewer hot flashes, and less pain compared to those taking…
Receptor discordance in metastatic breast cancer lesions associated with poorer overall survival in a retrospective cohort study
Oncology Cohort
Receptor discordance in metastatic breast cancer lesions associated with poorer overall survival in a retrospective cohort study When breast cancer changes its targets, does the current treatment still work?
This single-center retrospective cohort study analyzed 436 paired lesion samples from patients with primary and metastatic breast cancer. Re…
Breast cancer often changes its targets, and when tumors lose the proteins doctors rely on, survival drops from 95 to 70 months depending on…
Residual disease after surgery linked to survival in low-grade serous ovarian cancer
Oncology Cohort
Residual disease after surgery linked to survival in low-grade serous ovarian cancer For This Ovarian Cancer, Surgery Is Everything—Chemo May Not Help
This observational retrospective study of 25 patients with low-grade serous ovarian cancer found that residual disease status after primary …
For a rare ovarian cancer, a new study suggests that the quality of surgery is the single most important factor for survival, challenging th…
Retrospective review of 230 Northwest Ohio colorectal cancer patients identified demographic, lifestyle, and molecular risk factors.
Oncology Cohort
Retrospective review of 230 Northwest Ohio colorectal cancer patients identified demographic, lifestyle, and molecular risk factors. More Young Adults Are Getting Colon Cancer — Here’s What’s Behind It
This retrospective chart review examined 230 patients with colorectal cancer from the Northwest Ohio region to identify risk factors. The st…
Colon cancer cases in adults aged 30 to 49 are rising fast, prompting new screening guidelines and a closer look at lifestyle risks in Ohio.
SinglePass Kronos device shows promise for liver biopsy tract closure in small series
Oncology Cohort
SinglePass Kronos device shows promise for liver biopsy tract closure in small series New Device Stops Liver Biopsy Bleeding Before It Starts
This case report series evaluated the SinglePass Kronos electrocautery device for closing biopsy tracts in patients undergoing liver mass bi…
This simple new tool could make liver biopsies much safer by sealing the needle track instantly, reducing the need for long hospital stays.
Retrospective observational study evaluates systemic therapy surveillance in brain metastases patients.
Oncology Guideline
Retrospective observational study evaluates systemic therapy surveillance in brain metastases patients. Observational study examines MRI surveillance patterns in patients with active brain metastases
This retrospective observational study abstract examines surveillance practices in 33 patients with active brain metastases treated with sys…
Doctors monitoring brain metastasis patients with new drugs found no difference in tumor growth or radiation needs whether they followed gui…